Evaluation of Factor V Leiden, Prothrombin G20210A, MTHFR C677T and MTHFR A1298C gene polymorphisms in retinopathy of prematurity in a Turkish cohort

Ethnic Differences in the Association of Thrombophilic Polymorphisms with Obstetric Complications in Slovak and Roma (Gypsy) Populations

(2015) Alexandra Bozikova et al.   Genetic Testing and Molecular Biomarkers

Risk factors for retinopathy of prematurity: insights from outlier infants

(2014) Alexander D. Port et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients-results from the Vienna Cancer And Thrombosis Study (CATS)

(2014) I. Pabinger et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Venous thromboembolism in neonates and children

(2012) Gili Kenet et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity

(2011) Helen A. Mintz-Hittner et al.   NEW ENGLAND JOURNAL OF MEDICINE

INTRAVITREAL BEVACIZUMAB AS SUPPLEMENTAL TREATMENT OR MONOTHERAPY FOR SEVERE RETINOPATHY OF PREMATURITY

(2011) Ruth Axer-Siegel et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Genetic Mutations in Turkish Population With Pulmonary Embolism and Deep Venous Thrombosis

(2010) Elif Kupeli et al.   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

Prevalence of Thrombophilic Mutations and ACE I/D Polymorphism in Turkish Ischemic Stroke Patients

(2008) Gulay Celiker et al.   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

DIODE LASER TREATMENT OF RETINOPATHY OF PREMATURITY

(2008) RUTH AXER-SIEGEL et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES